Atlas Trials

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases

Clinical trial NCT06252454 · UNKNOWN

Trial details

NCT number
NCT06252454
Sponsor
University Hospital Hradec Kralove
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Dyspnea
Start date
2024-02-27
Primary completion
2024-12-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.